ask="60.00"
ask_size="500"
average_daily_volume="213642"
bid="30.00"
bid_size="200"
book_value="3.79"
change="+0.01"
change_from_200_day_moving_average="5.82"
change_from_50_day_moving_average="3.65"
change_from_52_week_high="-1.06"
change_From_52_week_low="17.12"
change_in_percent="+0.03%"
close="31.24"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-2.97"
ex_dividend_date="N/A"
float_shares="15631000"
high="31.36"
high_52_weeks="32.30"
last_trade_date="3/1/2017"
last_trade_price="31.24"
last_trade_size="8607"
last_trade_time="4:00pm"
low="30.40"
low_52_weeks="14.12"
market_capitalization="669.54M"
moving_average_200_day="25.42"
moving_average_50_day="27.59"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="31.10"
pe_ratio="N/A"
peg_ratio="-0.23"
percent_change_from_200_day_moving_average="+22.91%"
percent_change_from_50_day_moving_average="+13.22%"
percent_change_from_52_week_high="-3.28%"
percent_change_from_52_week_low="+121.25%"
previous_close="31.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.25"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.47"
stock_exchange="NMS"
symbol="ACRS"
volume="539722"
weeks_range_52="14.12 - 32.30"
